The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics
Phase of Trial: Phase III
Latest Information Update: 11 Apr 2016
At a glance
- Drugs Montelukast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 06 Apr 2016 Time frame for primary endpoint (Asthma Control Test (ACT) Scores) changed from 0, 4, 8, 12, 16, 20, 24 weeks to 24 weeks as reported by ClinicalTrials.gov.
- 15 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.